Autophagy and Supplements: What Fasting, NMN and Spermidine Do to Cellular Cleanup

Autophagy and Supplements is one of the most searched topics in longevity science right now, and for good reason. Your cells have a built-in recycling program that clears out damaged proteins and dysfunctional mitochondria, and certain compounds appear to help switch it on. The question is whether supplements can meaningfully activate autophagy in humans—or if the evidence is still mostly confined to cells and rodents.

What the Human Evidence Actually Shows

Let's be direct: robust human trials on autophagy activation by supplements are limited. Most mechanistic data comes from in vitro studies, yeast, or rodent models. The human studies we do have focus on downstream biomarkers—NAD+ levels, muscle function, metabolic parameters—rather than direct autophagy flux measurements, which require invasive muscle biopsies or specialized imaging.

The NMN human trial literature is the most relevant here because NMN raises NAD+, and NAD+ is a cofactor for sirtuins, which regulate autophagy-related genes. Yoshino et al. (2021) conducted a randomized, placebo-controlled, crossover trial in 25 postmenopausal women with prediabetes. Participants received 250 mg NMN daily for 10 weeks. The result: NMN increased muscle insulin sensitivity, measured via hyperinsulinemic-euglycemic clamp, and upregulated expression of genes involved in muscle remodeling. The study did not measure autophagy directly, but the gene expression changes are consistent with improved cellular quality control.

Igarashi et al. (2022) studied 20 healthy older men given 250 mg NMN daily for 12 weeks. NAD+ metabolites in whole blood increased significantly. Grip strength improved in the NMN group, and gait speed showed a trend toward improvement. Again, no direct autophagy readout, but the functional gains in older adults align with the hypothesis that restoring NAD+ supports cellular maintenance programs.

Irie et al. (2020) administered NMN to 10 healthy Japanese men at doses of 100, 250, and 500 mg. Even at 100 mg, blood NAD+ metabolites rose. No adverse effects were reported at any dose. This dose-ranging data is useful for understanding how low one can go and still see a metabolic signal.

Liao et al. (2021) tested NMN in 48 amateur runners for 6 weeks at 300–1200 mg/day. Aerobic capacity (VO2 max and ventilatory threshold) improved in the higher-dose groups. This suggests that NMN's effects may be more pronounced when combined with exercise, which itself is a potent autophagy trigger.

Niu et al. (2023) reported that 8 weeks of NMN supplementation in middle-aged adults influenced serum metabolites and telomere length. The study was small and the telomere finding requires replication, but it adds to the pattern that NMN affects markers of cellular aging.

The bottom line on human data: NMN consistently raises NAD+ metabolites and shows signals of improved muscle and metabolic function. Whether this occurs via autophagy activation or through parallel pathways remains unproven in humans.

The Mechanism: How Autophagy Works

Autophagy—literally "self-eating"—is a lysosomal degradation pathway. Cells package damaged organelles, misfolded proteins, and intracellular pathogens into double-membrane vesicles called autophagosomes. These fuse with lysosomes, where enzymes break down the cargo into amino acids, fatty acids, and sugars that can be recycled.

The process is regulated by several nutrient-sensing pathways. mTOR (mechanistic target of rapamycin) is the brake. When nutrients are abundant—especially amino acids and insulin—mTOR suppresses autophagy. When nutrients are scarce, as during fasting or calorie restriction, mTOR activity drops and autophagy ramps up. AMPK, the cellular energy sensor, also promotes autophagy when ATP is low.

NAD+ sits upstream of sirtuins, particularly SIRT1 and SIRT3. Gomes et al. (2013) showed that declining NAD+ during aging disrupts nuclear-mitochondrial communication and creates a pseudohypoxic state. Restoring NAD+ may reactivate sirtuin signaling, which in turn deacetylates autophagy-related proteins like LC3 and Beclin-1. In rodent models, this has been shown to enhance mitophagy—the selective clearance of damaged mitochondria.

Spermidine operates through a different but convergent pathway. It inhibits acetyltransferase EP300, which removes the acetyl groups from autophagy proteins, thereby activating them. Spermidine also induces autophagy transcriptionally via TFEB, the master regulator of lysosomal biogenesis. Unlike NMN, spermidine does not require NAD+ or sirtuins, though the two pathways may synergize.

Fasting remains the most validated autophagy trigger in humans. A 24-hour fast in humans increases autophagy markers in muscle, and prolonged fasting (48–72 hours) produces more robust signals. The challenge is adherence and safety, particularly for older adults or those with metabolic conditions.

NMN, Spermidine, and Fasting: A Comparison

Intervention	Primary Mechanism	Human Evidence Strength	Typical Dosing in Trials	Key Limitation
NMN	NAD+ → sirtuin activation → autophagy gene expression	Moderate (NAD+ and metabolic outcomes)	250–1200 mg/day	No direct autophagy flux data in humans
Spermidine	EP300 inhibition; TFEB-mediated lysosomal biogenesis	Limited (small trials; mostly mechanistic)	1–3 mg/day (supplement); higher from diet	Few RCTs; wheat germ extract is common source
Fasting (24–72h)	mTOR suppression; AMPK activation	High for autophagy markers	Water-only or very-low-calorie	Adherence; contraindicated for some populations
NMN + Exercise	Additive NAD+ and AMPK signaling	Moderate (Liao 2021)	300–1200 mg/day + training	Unclear if autophagy-specific or general metabolic

This table highlights a critical point: fasting has the strongest direct evidence for autophagy activation in humans, while NMN has the strongest human trial base among supplements for raising NAD+ and improving muscle and metabolic outcomes. Spermidine is mechanistically compelling but clinically underexplored.

What the Evidence Doesn't Show

There is no human trial demonstrating that NMN or spermidine directly increases autophagic flux as measured by LC3-II turnover or p62 degradation. The studies cited above show metabolic and functional improvements that are consistent with improved cellular quality control, but consistency is not proof.

We also lack head-to-head trials comparing NMN versus spermidine versus fasting. It is entirely possible that these interventions act on different cell types or under different metabolic conditions. NMN may be more relevant to muscle and neuronal tissue where NAD+ decline is pronounced. Spermidine may be more relevant to immune cells and cardiomyocytes based on preclinical work.

Long-term safety data beyond 12 weeks is sparse. NMN has shown an excellent short-term safety profile, but trials in thousands of participants for years do not exist. This is standard for emerging nutraceuticals, but it matters when evaluating risk-benefit for healthy individuals.

Finally, autophagy is not always beneficial. Excessive or poorly timed autophagy can degrade functional proteins and organelles. The "more is better" assumption is biologically naive. What most researchers aim for is restoration of youthful autophagic capacity, not chronic overactivation.

Who Benefits Most

The evidence is strongest for older adults with declining NAD+ and muscle function. Igarashi et al. (2022) specifically recruited men aged 65 and older, and the functional improvements in grip strength suggest this is a responsive population. The mechanism—restoring NAD+ to support sirtuin signaling—aligns with the biological changes of aging described by Gomes et al. (2013).

Prediabetic women may also see meaningful metabolic benefits. Yoshino et al. (2021) demonstrated improved muscle insulin sensitivity in this group, which is clinically significant given the role of muscle in glucose disposal. Whether this translates to reduced diabetes progression requires longer trials.

Endurance athletes represent a third group with emerging evidence. Liao et al. (2021) showed dose-dependent improvements in aerobic capacity, suggesting that NMN may support the mitochondrial biogenesis and quality control demands of high training volumes. For more on how NMN interacts with metabolic stressors, see our article on NMN and Fasting.

Healthy young adults are the least certain population. Irie et al. (2020) showed that NMN raises NAD+ metabolites in this group, but whether this produces functional benefits when autophagy is already operating efficiently is speculative.

Practical Takeaways

• Fasting is the most validated autophagy trigger. A 24–48 hour fast, done safely, is the only intervention with direct human evidence for increasing autophagy markers.
• NMN raises NAD+ consistently across trials. Doses of 250–500 mg/day have shown metabolic and functional effects in humans. For those considering supplementation, Bio:sudo NMN 1000mg provides a dose at the upper end of the studied range.
• Spermidine is mechanistically promising but clinically early. If you prefer food-first approaches, wheat germ, aged cheese, and mushrooms are rich sources.
• Exercise amplifies NMN effects. Liao et al. (2021) found aerobic improvements only in the context of training. Do not expect supplements to replace physical activity.
• Do not chase "maximum autophagy." The goal is restored, balanced cellular cleanup—not chronic overactivation. More is not necessarily better.
• Consult a clinician if you have medical conditions. Fasting and supplements can interact with medications and metabolic disorders.

For a broader review of the evidence behind longevity-focused compounds, see our guide to Anti-Aging Supplements Evidence. If you're specifically interested in how NAD+ declines with age and whether NMN can address it, our deep dive on NMN and Aging covers the mechanistic details.

Bottom Line

Autophagy is a real, biologically important process, and fasting is the only intervention with direct human evidence for activating it. NMN has the strongest human trial base among supplements for raising NAD+ and improving muscle and metabolic function—outcomes consistent with better cellular quality control—but direct proof of autophagy activation in humans remains elusive. Spermidine is mechanistically compelling but needs larger, longer trials. If you choose to supplement, do so with realistic expectations: these are support tools, not replacements for the fundamentals of sleep, exercise, and periodic fasting.

References

1. Yoshino M, et al. "Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women." Science. 2021;372(6547):1224–1229. [Source]
2. Igarashi M, et al. "Chronic nicotinamide mononucleotide supplementation elevates blood nicotinamide adenine dinucleotide levels and alters muscle function in healthy older men." npj Aging. 2022;8(1):5. [Source]
3. Irie J, et al. "Effect of oral administration of nicotinamide mononucleotide on clinical parameters and nicotinamide metabolite levels in healthy Japanese men." Endocrine Journal. 2020;67(2):153–160. [Source]
4. Liao B, et al. "Nicotinamide mononucleotide supplementation enhances aerobic capacity in amateur runners: a randomized, double-blind study." Journal of the International Society of Sports Nutrition. 2021;18(1):54. [Source]
5. Gomes AP, et al. "Declining NAD+ induces a pseudohypoxic state disrupting nuclear-mitochondrial communication during aging." Cell. 2013;155(7):1624–1638. [Source]
6. Niu KM, et al. "The impacts of short-term NMN supplementation on serum metabolism, fecal microbiota, and telomere length in pre-aging phase." Nutrients. 2023;15(3):755. [Source]

---

---